Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

Raphaël Marlu,J Barthelon,A. Durand,N Mathieu,C. Barro,V. Granger,A Tatu,G. Pernod,Benoit Polack,Bruno Bonaz

Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

2015

Raphaël Marlu
J Barthelon
A. Durand
N Mathieu
C. Barro
V. Granger
A Tatu
G. Pernod
Benoit Polack
Bruno Bonaz

Long-Term Therapy With Bevacizumab in a Patient With Glanzmann’s Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions

Keywords:

Thrombasthenia
Bevacizumab
Glanzmann's thrombasthenia
Surgery
Diabetes mellitus
Medicine
long term therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations